LIFE - Atyr Pharma Inc
Close
1.9
0.050 2.632%
Share volume: 269,477
Last Updated: Tue 04 Jun 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.85
0.05
2.70%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-10 | 2022-08-15 | 2022-11-14 | 2023-03-14 | 2023-05-09 | 2023-08-09 | 2023-11-09 | |
| Cash flow financing | 1.481 M | 39.000 K | 3.013 M | 918.000 K | 49.496 M | 8.018 M | 2.682 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -10.119 M | -9.117 M | -12.281 M | -10.369 M | -590.000 K | -12.010 M | -9.559 M | |
| Net income | -12.153 M | -12.420 M | -13.244 M | -7.521 M | -11.951 M | -12.338 M | -11.340 M | |
| Depreciation | 298.000 K | 286.000 K | 414.000 K | 697.000 K | 755.000 K | 586.000 K | 993.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 14.626 M | 9.971 M | 20.649 M | 1.999 M | -38.172 M | -4.156 M | 4.383 M | |
| Net Borrowings | -101.972 M | -92.081 M | -75.982 M | -69.337 M | -105.160 M | -99.040 M | -92.080 M | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -43.000 K | -53.000 K | -426.000 K | -1.119 M | -1.246 M | -2.395 M | -557.000 K | |
| Cash Change | 98.666 M | 88.554 M | 77.374 M | 66.146 M | 114.385 M | 108.581 M | 102.131 M |